Suppr超能文献

双侧肾母细胞瘤:19例单中心经验

Bilateral Wilms' tumors: a single-center experience with 19 cases.

作者信息

Millar Alastair J W, Davidson Alan, Rode Heinz, Numanoglu Alp, Hartley Patricia S, Daubenton John D, Desai Farieda

机构信息

Department of Paediatric Surgery, Red Cross Children's Hospital, School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa.

出版信息

J Pediatr Surg. 2005 Aug;40(8):1289-94. doi: 10.1016/j.jpedsurg.2005.05.013.

Abstract

BACKGROUND/PURPOSE: Bilateral Wilms' tumors present a therapeutic challenge, particularly with delay in presentation, when there is poor response to chemotherapy and when associated with nephroblastomatosis. The primary aim of management is eradication of neoplasm, while at the same time preserving of renal function.

METHODS

Nineteen bilateral Wilms' tumors were seen in our service between 1981 and 2003. This represented 10% of the 190 patients with Wilms' tumors seen during this period. There were 12 female and 7 male patients ranging in age from 7 months to 8 years. Fourteen had synchronous presentation, one of whom had liver metastasis at diagnosis. Of the 5 patients with metachronous tumors, 3 had their initial nephrectomies done elsewhere. Nephroblastomatosis was identified in 18 (95%) of the patients. Treatment was, in most cases, according to National Wilms Tumor Study Group protocols, with initial bilateral biopsy, neoadjuvant chemotherapy, and tumorectomy. Where indicated, nephrectomy (partial or complete) involved using ice dam topical cooling and vascular control, and in one case, bench surgery and extensive renal reconstruction with orthotopic autotransplantation. Revision tumorectomy was used on 3 occasions for recurrence in areas of nephroblastomatosis. There were 6 extrarenal relapses.

RESULTS

Ten patients are alive and free of disease 1 to 15 years after treatment, all with well preserved renal function (lowest recorded glomerular filtration rate was 85 mL/min per 1.73 m2). Nine have died (2 of unrelated disease), including 6 of the 7 with spread outside the kidney. All 3 with unfavorable histology are alive. Of the 5 with metachronous presentations, 4 are alive, as are 7 of 10 who presented in the last decade.

CONCLUSIONS

Appropriate chemotherapy and conservative nephron-sparing and innovative surgery can achieve good results with preservation of adequate renal function in nearly all cases. Nephroblastomatosis was an almost universal finding and requires close monitoring because Wilms' tumors developed in residual suspect areas. Revision surgery was effective. Unfavorable histology did not have a reduced survival in our series. Metastatic spread outside the kidney had a poor prognosis.

摘要

背景/目的:双侧肾母细胞瘤带来了治疗挑战,尤其是出现就诊延迟、对化疗反应不佳以及与肾母细胞瘤病相关的情况时。治疗的主要目标是根除肿瘤,同时保留肾功能。

方法

1981年至2003年期间,我们科室共诊治了19例双侧肾母细胞瘤。这占同期190例肾母细胞瘤患者的10%。患者中女性12例,男性7例,年龄从7个月至8岁不等。14例为同时性发病,其中1例在诊断时伴有肝转移。在5例异时性肿瘤患者中,3例最初的肾切除术在其他地方进行。18例(95%)患者发现有肾母细胞瘤病。在大多数情况下,治疗遵循国家肾母细胞瘤研究组的方案,首先进行双侧活检、新辅助化疗,然后行肿瘤切除术。在必要时,肾切除术(部分或完全)采用冰帽局部降温及血管控制,1例患者采用体外手术及原位自体肾移植进行广泛的肾脏重建。3例患者因肾母细胞瘤病区域复发接受了再次肿瘤切除术。有6例出现肾外复发。

结果

10例患者在治疗后1至15年存活且无疾病,所有患者肾功能均保存良好(记录到的最低肾小球滤过率为85 mL/min/1.73 m²)。9例患者死亡(2例死于无关疾病),包括7例发生肾外转移患者中的6例。所有3例组织学类型不良的患者均存活。5例异时性发病患者中,4例存活,在过去十年中发病的10例患者中有7例存活。

结论

适当的化疗、保守的肾单位保留及创新手术在几乎所有病例中都能在保留足够肾功能的情况下取得良好效果。肾母细胞瘤病几乎普遍存在,需要密切监测,因为在残留可疑区域会发生肾母细胞瘤。再次手术有效。在我们的系列研究中,组织学类型不良并未导致生存率降低。肾外转移的预后较差。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验